Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus

Clinical and Experimental Immunology

Volumn 140, Issue 1, 2005, Pages 173-180

  Alessandri, C ^a   Bombardieri, M ^a   Di Prospero, L ^a   Conigliaro, P ^a   Conti, F ^a   Labbadia, G ^a   Misasi, R ^a   Sorice, M ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiphosholipid syndrome; Autoantibodies; Cardiolipin; Lyso(bis)phosphatidic acid; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; LYSOBISPHOSPHATIDIC ACID ANTIBODY; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY SPECIFICITY; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; MONOGLYCERIDES;

EID: 16244422005     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02727.x     Document Type: Article

References (37)

1. Hughes GR. The anticardiolipin syndrome. Clin Exp Rheumatol 1985; 3:285-6.
2. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42:1309-11.
3. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 355:1544-7.
4. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4.
5. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177-8.
6. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74:1120-5.
7. Sorice M, Griggi T, Circella A et al. Protein S antibodies in acquired protein S deficiencies. Blood 1994; 83:2383-4.
8. Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S. an explanation for their pathogenic mechanism? Blood 1993; 81:2618-25.
9. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997; 54:209-13.
10. Sorice M, Pittoni V, Griggi T et al. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol 2000; 120:301-6.
11. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG, Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 1998; 392:193-7.
12. Gruenberg J, Kreis TE. Membranes and sorting. Curr Opin Cell Biol 1995; 7:519-22.
13. Schmid SL, Cullis PR. Membrane sorting. Endosome marker is fat not fiction. Nature 1998; 392:135-6.
14. Sorice M, Ferro D, Misasi R et al. Evidence for anticoagulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb Haemost 2002; 87:735-41.
15. Galve-de Rochemonteix B, Kobayashi T et al. Interaction of antiphospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20:563-74.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
17. Fischer K, Chatterjee D, Torrelles J, Brennan PJ, Kaufmann SH, Schaible UE. Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2. J Immunol 2001; 167:2187-92.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193:265-75.
19. Horkko S, Olee T, Mo L et al. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta (2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation 2001; 103:941-6.
20. Horkko S, Miller E, Branch DW, Palinski W, Witztum JL. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci USA 1997; 94:10356-61.
21. Sorice M, Griggi T, Circella A et al. Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Meth 1994; 173:49-54.
22. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74:1185-90.
23. Sorice M, Circella A, Griggi T et al. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies. Thromb Haemost 1996; 75:303-8.
24. Zhu M, Olee T, Le DT et al. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antipospholipid syndrome reveals three species of antibodies. Br J Haematol 1999; 105:102-9.
25. Lieby P, Soley A, Levallois H et al. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogenicity. Blood 2001; 97:3820-8.
26. Prieto J, Yuste JR, Beloqui O et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23:199-204.
27. Ordi-Ros J, Villarreal J, Monegal F, Sauleda S, Esteban I, Vilardell M. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 2000; 7:241-4.
28. Nash MJ, Camilleri RS, Kunka S, Mackie IJ, Machin SJ, Cohen H. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004; 2:1077-81.
29. Reddel SW, Krilis SA. Testing for and clinical significance of anticardiolipin antibodies. Clin Diagn Lab Immunol 1999; 6:775-82.
30. Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. J Rheumatol 1989; 16:614-17.
31. Finazzi G, Brancaccio V, Moia M et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996; 100:530-6.
32. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 1998; 104:332-8.
33. Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - a meta-analysis. Lupus 1997; 6:467-73.
34. Cheng HM. Cell penetration by antiphospholipid autoantibodies. Immunol Today 1998; 19:49.
35. Laulagnier K, Motta C, Hamdi S et al. Mast cell and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J 2004; 380:161-71.
36. Stinton LM, Eystathioy T, Selak S, Chan EK, Fritzler MJ. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol 2004; 110:30-44.
37. Sorice M, Circella A, Cristea IM et al. Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Diff 2004; 11:1133-45.